Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.210
-0.400 (-15.33%)
At close: Oct 17, 2025, 4:00 PM EDT
2.300
+0.090 (4.07%)
After-hours: Oct 17, 2025, 7:58 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $104.15 million as of October 17, 2025. Its market cap has increased by 116.09% in one year.
Market Cap
104.15M
Enterprise Value
-73.05M
1-Year Change
116.09%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since August 9, 2017, Whitehawk Therapeutics's market cap has decreased from $162.50M to $104.15M, a decrease of -35.91%. That is a compound annual growth rate of -5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 104.20M | 33.93% |
| Dec 31, 2024 | 77.80M | 57.17% |
| Dec 29, 2023 | 49.50M | -84.19% |
| Dec 30, 2022 | 313.00M | -37.97% |
| Dec 31, 2021 | 504.60M | 992.21% |
| Dec 31, 2020 | 46.20M | 82.61% |
| Dec 31, 2019 | 25.30M | -63.33% |
| Dec 31, 2018 | 69.00M | -46.35% |
| Dec 29, 2017 | 128.60M | -20.86% |
| Aug 9, 2017 | 162.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |